trending Market Intelligence /marketintelligence/en/news-insights/trending/fnz8u24-ebi_2lwaxvqbnw2 content esgSubNav
In This List

Ionis Pharmaceuticals appoints chief business officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Ionis Pharmaceuticals appoints chief business officer

Ionis Pharmaceuticals Inc. appointed Damien McDevitt as chief business officer.

The Carlsbad, Calif.-based biotechnology company said McDevitt previously served as senior vice president of corporate development at ACADIA Pharmaceuticals Inc.

Prior to joining ACADIA, McDevitt worked at GlaxoSmithKline PLC in several roles for more than 20 years.